Johnny Mobasher Lrps

1854 is a digital media business curating the best contemporary photography for an international audience of arts & culture lovers and creators. Since raising £400k at a £3m valuation in 2016 weve grown commercial and awards income and profitability, transitioned to a data driven mindset based on lean startup principles and won 6 awards including Publishing Innovator of the year, Digital Innovation of the year and Consumer Media Brand of the year. Our primary platforms are: British Journal of Photography The oldest photography magazine in the world (est 1854) and an influential authority in the photography community globally. With growing reach of 3 million+ monthly, BJP is our cornerstone and enabler. 1854 Creates In-house creative studio launched in 2017 working with brands to create visually compelling PR-able content that travels well on social media, working with our global talent pool and achieving outstanding results. We are currently scaling up and hiring. Please contact creates@1854.media for more information about what we can do for your brand. 1854 Awards Launched in 2016 Portrait of Britain became the most viewed photographic exhibition in the world, adding to our awards program which includes Breakthrough and the International Photography Awards. With two ambitious launches planned for 2018 this is a growing and exciting part of our business. Find out more at http://1854.media Recently awarded the coveted PPA Publishing Innovator of the year for the second time, the PPA judges said: “The passion, drive, and dedication of this small hard-working team really stood out, their focus on creativity and innovation is exemplary. 1854 Media’s win is a fitting reward for a brave and determined approach”.

Oxford Cannabinoid Holdings Plc is the holding company of Oxford Cannabinoid Technologies Ltd, a UK-based pharmaceutical company, which uses cutting-edge technology and a drug development strategy to explore the potential of cannabinoid derivatives, phytocannabinoids, and other drug candidates on the endocannabinoid system, and bring pioneering treatments to market. OCT believes it is important to develop a deeper understanding of the molecular actions of cannabinoids. We manage a wide-ranging research program that investigates the medical potential of cannabinoids across different therapeutic areas, with a particular focus on pain. By employing the latest scientific techniques to provide more evidence that supports the positive effects of cannabinoids, it is our vision to become a global leader in developing cannabinoid-based prescription medication, improving the quality of life for millions of patients.

1854 is a digital media business curating the best contemporary photography for an international audience of arts & culture lovers and creators. Since raising £400k at a £3m valuation in 2016 weve grown commercial and awards income and profitability, transitioned to a data driven mindset based on lean startup principles and won 6 awards including Publishing Innovator of the year, Digital Innovation of the year and Consumer Media Brand of the year. Our primary platforms are: British Journal of Photography The oldest photography magazine in the world (est 1854) and an influential authority in the photography community globally. With growing reach of 3 million+ monthly, BJP is our cornerstone and enabler. 1854 Creates In-house creative studio launched in 2017 working with brands to create visually compelling PR-able content that travels well on social media, working with our global talent pool and achieving outstanding results. We are currently scaling up and hiring. Please contact creates@1854.media for more information about what we can do for your brand. 1854 Awards Launched in 2016 Portrait of Britain became the most viewed photographic exhibition in the world, adding to our awards program which includes Breakthrough and the International Photography Awards. With two ambitious launches planned for 2018 this is a growing and exciting part of our business. Find out more at http://1854.media Recently awarded the coveted PPA Publishing Innovator of the year for the second time, the PPA judges said: “The passion, drive, and dedication of this small hard-working team really stood out, their focus on creativity and innovation is exemplary. 1854 Media’s win is a fitting reward for a brave and determined approach”.

Oxford Cannabinoid Holdings Plc is the holding company of Oxford Cannabinoid Technologies Ltd, a UK-based pharmaceutical company, which uses cutting-edge technology and a drug development strategy to explore the potential of cannabinoid derivatives, phytocannabinoids, and other drug candidates on the endocannabinoid system, and bring pioneering treatments to market. OCT believes it is important to develop a deeper understanding of the molecular actions of cannabinoids. We manage a wide-ranging research program that investigates the medical potential of cannabinoids across different therapeutic areas, with a particular focus on pain. By employing the latest scientific techniques to provide more evidence that supports the positive effects of cannabinoids, it is our vision to become a global leader in developing cannabinoid-based prescription medication, improving the quality of life for millions of patients.